Associated Papers
Bridging pleiotropic mechanisms in leprosy type-1 reactions and neurodegenerative diseases.
Fava VM et al.
Scientific Reports, 2025
41430073 (PubMed )
Supplement: 41598_2025_30734_MOESM2_ESM.xlsx › Variants
Apolipoprotein E (APOE) Haplotypes in Healthy Subjects from Worldwide Macroareas: A Population Genetics Perspective for Cardiovascular Disease, Neurodegeneration, and Dementia.
Abondio P et al.
Current Issues in Molecular Biology, 2023
37185708 (PubMed )
Supplement: cimb-45-00184-s001.zip › cimb-2284441-supplementary › CIMB_APOE_supplementary.xlsx › Supplementary_Table_S1
Genome sequencing reveals the role of rare genomic variants in Chinese patients with symptomatic intracranial atherosclerotic disease.
Shi M et al.
Stroke and Vascular Neurology, 2022
34880113 (PubMed )
Supplement: svn-2021-001157supp001.pdf
Apolipoprotein E and Alzheimer's disease.
Troutwine BR et al.
Acta Pharmaceutica Sinica. B, 2022
Genetics of synucleins in neurodegenerative diseases.
Brás J et al.
Acta Neuropathologica, 2021
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein.
Guan Y et al.
Frontiers in Cellular Neuroscience, 2020
Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.
Zhou Y et al.
Journal of Lipid Research, 2018
In silico analyses of deleterious missense SNPs of human apolipoprotein E3.
Pires AS et al.
Scientific Reports, 2017
The apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes).
McIntosh AM et al.
Plos One, 2012
Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease.
Pocathikorn A et al.
Atherosclerosis, 2003
Select a paper to view details